Interpreting a high volume of mammograms ma not lead radiologists to find more cancers but my help them to better distinguish between malignant and non-malignant lesions, according to research published online Feb. 22 in Radiology.
TUESDAY, Feb. 22 (HealthDay News) -- Interpreting a high volume of mammograms may not lead radiologists to find more cancers but may help them to better distinguish between malignant and non-malignant lesions, according to research published online Feb. 22 in Radiology.
Diana S.M. Buist, Ph.D., M.P.H., of the Group Health Cooperative in Seattle, and colleagues collected annual interpretive volume measures from 120 radiologists between 2002 and 2006 to investigate whether interpretive volume has an effect on screening mammography performance.
The researchers found that performance varied by number of exams performed and by the ratio of screening to total mammograms. The mean sensitivity of 85.2 percent did not vary significantly by total, screening, or diagnostic volume, though it was significantly lower for those with a greater screening focus. The mean false-positive rate was 9.1 percent, and the false-positive rate was significantly higher for those with lowest total and screening volumes. Radiologists who had a low diagnostic volume and a greater screening focus had significantly lower rates of false positives and cancer detection, respectively.
"Increasing minimum interpretive volume requirements in the United States while adding a minimal requirement for diagnostic interpretation could reduce the number of false-positive work-ups without hindering cancer detection. These results provide detailed associations between mammography volumes and performance for policymakers to consider along with work force, practice organization, and access issues and radiologist experience when reevaluating requirements," the authors write.
One author disclosed financial ties to Hologic.
Related Content
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More